Suchergebnisse - "Amiot, Aurélien"

PubPharm (223)

11

14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication : A multicenter, open‐label randomized noninferiority controlled trial

enthalten in: Helicobacter | 2024

von Amiot, A. | Hacoon, J. | Heluwaert, F. | +8

12

Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess : A Prospective Study From the GETAID

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Bouhnik, Y. | Pineton de Chambrun, G. | Lambert, J. | +35

13

Obesity in adult patients with inflammatory bowel disease : Clinical features and impact on disability. A cross-sectional survey from the GETAID

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Bacha, R. | Bouhnik, Y. | Serrero, M. | +105

14

Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease : The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif

enthalten in: Clinical and translational gastroenterology | 2023

von Guillo, L. | Savoye, G. | Amiot, A. | +22

CommentIn: Clin Transl Gastroenterol. 2023 Dec 01;14(12):e00618. - PMID 38156785

15

Prevalence and Determinants of Fatigue in Patients with IBD : A Cross-Sectional Survey from the GETAID

enthalten in: Journal of Crohn's & colitis | 2023

von Amiot, A. | Chaibi, S. | Bouhnik, Y. | +111

16

Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Uzzan, M. | Nachury, M. | Amiot, A. | +4

17

Editorial : in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Meyer, A. | Amiot, A. | Carbonnel, F.

CommentOn: Aliment Pharmacol Ther. 2023 Feb;57(4):399-408. - PMID 36645152

18

Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Carbonnel, F. | Routier, E. | Lazure, T. | +9

CommentIn: Aliment Pharmacol Ther. 2023 Apr;57(7):808-809. - PMID 36913503

19

Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease : Results From the Nationwide ACCEPT2 Study

enthalten in: Inflammatory bowel diseases | 2023

von Buisson, A. | Serrero, M. | Orsat, L. | +22

20

Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease : A Multicentre Case-Control Study

enthalten in: Cancers | 2023

von Chappe, C. | Salut, C. | Amiot, A. | +16